跳至主要内容
临床试验/NCT01297426
NCT01297426撤回不适用

Leptin Signaling in Humans

VA Office of Research and Development1 个研究点 分布在 1 个国家开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Westerns / activation of signaling pathways (uo to two hours after treatment)

研究概览

简要总结

Obesity does not respond to high circulating levels of the hormone leptin. This study is aiming at finding out why this happens and open new avenues for treatment of obesity.

详细描述

Ex vivo and in vitro identification and study of leptin signaling pathways in commercially available cell lines serum/ plasma samples and discarded tissues from humans.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • men and women
  • ages 18 to 65
  • BMI ranges between 20 and 45 kg/m2

排除标准

  • subjects requiring special diets
  • history of illness other than obesity of diabetes
  • taking medications known to influence glucose metabolism
  • subjects with history of anaphylactic reaction or hypersensitivity to e. coli derived proteins or anesthetic agents
  • women who are breastfeeding, pregnant or wanting to become pregnant
  • subjects with bleeding dyscrasia or poor wound healing

结局指标

主要结局

Westerns / activation of signaling pathways (uo to two hours after treatment)

时间窗: 04/01/2016

次要结局

未报告次要终点

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验